Initial Therapeutics
New York, NY
Initial Therapeutics is an ATP company that develops small-molecule medicines designed to prevent pathogenic protein synthesis. The company provides an approach that is differentiated from protein degradation and other interventions that recognize and tackle proteins only after they are fully formed... Read more
initialtx.comCompany Details
Founded
- 2020
Employees
- Between 10 - 50 employees
Raised
- $78,800,000
Headquarters Location
- New York, NY
Public
- No
Acquired
- No
CEO
Peter DiLaura
Founders
- Brian PaegelJamie CateKevan ShokatSpiros Liras
Company Collections
These are collections Initial Therapeutics is a part of. Click on the collection name to view similar companies.